Video Experimental Relacionado
Updated: Jul 13, 2026
04:24
A Mouse Distraction Osteogenesis Model
Published on: November 14, 2018
6.4K
La carga acumulada de comorbilidades en las complicaciones posteriores a la distracción mandibular Osteogénesis en la
Asli Pekcan1,2, Raina K Patel2, Valeria Mejia1,2
1Division of Plastic and Reconstructive Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Resumen
Las comorbilidades aumentan significativamente las complicaciones importantes y las readmisiones después de la osteogénesis por distracción mandibular (MDO) para la apnea obstructiva del sueño (AOS) en pacientes con secuencia de Robin (RS). La evaluación preoperatoria cuidadosa y el seguimiento postoperatorio son cruciales para el manejo de estos niños de alto riesgo.
Área de la Ciencia:
- Cirugía pediátrica
- Cirugía craneofacial
- Medicamento para el sueño
Sus antecedentes:
- La osteogénesis por distracción mandibular (MDO) es un tratamiento clave para la apnea obstructiva del sueño (AOS) en pacientes con secuencia de Robin (RS).
- No se comprende bien la influencia de las afecciones médicas coexistentes (comorbilidades) en los resultados de MDO en pacientes con RS.
- Este estudio investiga el impacto de la carga de comorbilidad en las complicaciones postoperatorias después de la MDO en RS.
Objetivo del estudio:
- Evaluar la asociación entre las condiciones comórbidas y las complicaciones postoperatorias después de la MDO en pacientes con Robin Sequence.
- Para identificar comorbilidades específicas que predicen complicaciones importantes, readmisiones y reoperaciones.
- Determinar el efecto acumulativo de múltiples comorbilidades en los resultados de la EMD.
Principales métodos:
- Estudio de cohorte retrospectivo de 86 pacientes con secuencia de Robin sometidos a MDO entre 2004 y 2023 en un hospital infantil terciario.
- Los datos recopilados incluyeron la demografía de los pacientes, las comorbilidades (respiratoria, cardíaca, hipotonía, gastrointestinal), el estado de intubación preoperatoria y la duración del seguimiento.
- Los resultados primarios evaluados fueron complicaciones importantes, readmisiones hospitalarias y reoperaciones, analizadas utilizando regresión logística multivariable.
Principales resultados:
- El 27,9% de los pacientes experimentó complicaciones importantes, el 12,8% requirió readmisión y el 19,8% se sometió a una reoperación.
- Las comorbilidades respiratorias y cardíacas fueron predictores independientes de complicaciones importantes (P < .05).
- Cada comorbilidad adicional aumentó las probabilidades de complicaciones mayores en 2,7 veces (P = .012) y de readmisión en 4,2 veces (P = .008).
Conclusiones:
- La carga de comorbilidades tiene un impacto significativo en el riesgo de complicaciones importantes, readmisión y reoperación después de la MDO en pacientes con RS.
- La intubación preoperatoria es un predictor de la readmisión, enfatizando la necesidad de un manejo respiratorio cuidadoso.
- El cribado preoperatorio mejorado, la estratificación del riesgo, el asesoramiento al paciente y el seguimiento postoperatorio cercano son esenciales para los pacientes de alto riesgo que se someten a MDO.
Videos de Conceptos Relacionados
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...